HEALTH product giant Allergan has announced it will follow Australia’s lead and market its stomach-shrinking Lap-Band to US doctors treating people at the low end of the obesity scale.

Until now, US physicians used the surgically implanted device only for seriously obese people, although it has been used for more than a decade to treat Australians with a body mass index of 30 and one obesity-related health issue.

To read the full story, click here: